Search Results

Search results for clinical governance

516. 25 - Supporting Staff by Mentoring as well as Managing

Supporting Staff by Mentoring as well as ManagingDay: Friday | Time: 13:30 - 15:00Session Coordinators: Bill ChaffePresentations TBCIntended AudienceTBCLearning ObjectivesTBCBrief DescriptionTBCSession TagsTBC

517. 28 - TP Symposium

TP SymposiumSupport for TP’s: What is out there?Day: Friday | Time: 09:00 - 10:30 | Room: Queens Suite 2Session Coordinators: Aine McCartneySpeakers: Structures, support and sharing for UK Transfusion PractitionersKathleen Wedgeworth, Northern Devon Healthcare NHS TrustDownload PresentationTraining Framework and Competencies for Transfusion PractitionersAndrew Miller, King’s Health Partners Haematology Institute and NetworkD

518. 30 - Advanced Case Studies

Advanced Clinical and Laboratory Cases - have your sayDay: Friday | Time: 13:30 - 15:00 | Room: Queens Suite 1Session Coordinators: Therese Callaghan & Tracey TomlinsonSpeakers: Case Study 1 Mark Dwight, NHSBTDownload PresentationCase Study 2 Dr Khaled El-Ghariani, NHSBTPresentation UnavailableCase Study 3Dr Louise Garth, Royal Liverpool University Hospital, UKDownload PresentationCase Study 4Dr Matt Hazell, NHSBTDownload Prese

519. ISBT launches ISBT In Focus

ISBT launches ISBT In Focus - its second virtual congress : 2nd -8th June , 2021#ISBT In Focus, a dedicated 7-day virtual congress for transfusion medicine professionals seeking to explore the latest updates on blood transfusion. This major virtual event will include state of lectures, educational interactive sessions, short presentations, e-posters, and sponsored content - all focused on a specific areas of transfusion practice: Red Cell Immunohaematology, Platelets & Granulocyte Immun

520. Unit 1 - Transfusion Science Practice

Unit 1 - Transfusion Science PracticeIndicative ContentIn this unit, you will learn about:Human Immune Response with regard to blood groups and transfusionMajor blood group systems Clinical Significance of blood group antibodiesBasic overview of haemolytic disease of the fetus/ newborn with respect to red cell antibodiesProcessing, testing and issuing of blood components (including the selection of blood donors)Pre-transfusion testing undertaken in UK transfusion laboratories Hazards a

[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] - Page 104 of 109 ( 545 results in total )

Member Login

BBTS Membership